Reed Seaton
Effective September 23, 2024, the Board of Directors (the “Board”) of SilverBox Corp IV (the “Company”) appointed Reed Seaton to the Board as a director of the Company.
Highest-materiality recent filing
SilverBox Corp IV SPAC to merge with Parataxis Holdings, a digital asset manager focused on Korea
Business Combination Agreement dated Aug 5, 2025, amended May 1, 2026.
Definitive agreement: Parataxis Holdings acquires controlling interest in Sinsiway Co. Ltd. for up to KRW 35 billion.
SilverBox Corp IV amends Preferred Equity Subscription Agreements to allow Bitcoin collateralization
Amendment removes prohibition on pledging Bitcoin purchased with $31M preferred equity proceeds.
SilverBox Corp IV (SBXD) will merge with Parataxis Holdings LLC; Pubco will become publicly traded on NYSE/Nasdaq.
SilverBox Corp IV signs definitive merger with Parataxis Holdings; Edward Chin gets 80% voting power
Base enterprise value of $100M; exchange ratio derived from $10 per unit, with additional adjustment for Bitcoin price appreciation.
Parataxis definitively acquires control of Bridge Bio for KRW 25B to create Bitcoin treasury company
Parataxis Holdings to invest KRW 25 billion for controlling interest in Bridge Biotherapeutics (KOSDAQ: 288330).
SilverBox Corp IV prices $200M IPO of 20M units at $10/unit, begins NYSE listing
IPO of 20,000,000 units at $10.00/unit grossed $200M before expenses and underwriter discounts.
Effective September 23, 2024, the Board of Directors (the “Board”) of SilverBox Corp IV (the “Company”) appointed Reed Seaton to the Board as a director of the Company.
On August 15, 2024, in connection with the IPO Matthew Eilers, Jonathan Lewis and Daniel E. Esters (the “ New Directors ” and, collectively with Stephen Kadenacy, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On August 15, 2024, in connection with the IPO Matthew Eilers, Jonathan Lewis and Daniel E. Esters (the “ New Directors ” and, collectively with Stephen Kadenacy, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On August 15, 2024, in connection with the IPO Matthew Eilers, Jonathan Lewis and Daniel E. Esters (the “ New Directors ” and, collectively with Stephen Kadenacy, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Max materiality 0.85 · Median 0.55 · Most common event other_material